US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Daiso Issues Allergy Alert on Undeclared Soy in Matsunga Mini Shiruko Sand Biscuits

      Summary Company Announcement Date: January 30, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Drug Recalls / What You Don’t Know About Generic Drugs, and How It Can Hurt You

What You Don’t Know About Generic Drugs, and How It Can Hurt You

July 17, 2017 By Sean Lally Leave a Comment

The Danger of Generic Drugs

It is very common for people to conflate generic drugs with their brand-name counterparts, but according to Jeremy Greene, a historian of medicine at Johns Hopkins, “The average American has a series of assumptions about generic and brand-name drugs that don’t hold up to historical scrutiny.” This conflation will become even more relevant if Donald Trump takes a crack at lowering pharmaceutical prices.

Any solution coming from the White House will most likely involve the empowerment of the generic drug market, an idea supported by some due to the $230 billion that were saved in 2015 because of generic medicines. The president would also like to rescind a measure blocking the federal government from negotiating drug prices, a move that has historically been supported by the Democrats.

All Prices Rising

However, though it’s true that Trump came into the Presidency amidst a 5,000 percent increase on the toxoplasmosis treatment Daraprim and a 400 percent increase on EpiPen, an anti-allergic injection, he must also face the reality of a rise in the price of generic drugs. Prices for around 400 generic drugs went up 1,000 percent between 2008 and 2015. So shifting the focus to generics may not be the panacea for our pharmaceutical woes.

Release Mechanism

What exactly are the differences between generic and brand-names medicines? To begin with, the synthesis of a drug like Cymbalta involves, not only the combination of active ingredients, but the development of a release mechanism. Many anti-depressants control the pace at which the medicinal substance is absorbed.

Patent Control and Emerging Markets

The point is that this mechanism is protected by its own separate patent, meaning generic companies must develop their own version. In some cases, the generic version of the release mechanism is not as effective as the brand-name version, a problem currently being considered by the FDA. According to the agency, one-third of the of top 200 prescribed drugs use modified release mechanisms. The FDA acknowledges in its ongoing study that generic producers need “tools that can assess the risks related to change in release mechanism.”

With the expansion of the global market, more and more pharmaceuticals are being produced off-shore in countries such as India and China, where, according to the FDA, there may have been some number-fudging in quality control tests. The FDA has had a hard time dealing with this issue because of a diminished staff.

Complaints

There are two widely circulated generic versions of Cymbalta: Lupin Ltd. (from India) and Teva Pharmaceutical Industries Ltd. (from Israel). When these generics were first sold in 2014, the FDA received 262 complaints from patients who had switched from Cymbalta to the knock-off drugs, according to an internal report obtained by Bloomberg. A majority of the complaints were in regard to Lupin and Teva, with 61 complaints directed at the former and 47 at the latter. Perhaps most troubling is the fact that these companies refuses to acknowledge any risks. And even more troubling than that? The FDA concurs.

FDA in Denial

Sandy Walsh, an FDA spokesperson, said all generic versions of Cymbalta are safe to use. She reasoned, in an email to Bloomberg, that new generics “tend to elicit a large number of patient complaints typically within the first year after approval.” This is somewhat surprising considering that the European Medicines Agency recommended suspending Lupin generic drugs (and others) because the company used flawed research from the Semler Research Centre to show that its release mechanism operated in the same way as Cymbalta. And Teva was forced to take a drug off the market in 2012 after discovering the release mechanism was ineffective.

With so many complaints and an insufficient number of FDA investigators in foreign offices, one hopes more is done to regulate these dangerous drugs.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: Drug Recalls, Safety News

About Sean Lally

Sean Lally holds a BA in Philosophy from Temple University where he also studied theatre for several years. Between 2007 and 2017, he worked as a professional actor for several regional theater companies in Philadelphia, including the Arden Theatre Co., EgoPo Productions, Lantern Theater and the Bearded Ladies. In 2010, Sean co-founded Found Theater Company, an avant-garde artist collective with whom he first started to cultivate an identity as a writer.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting
Accident Attorneys

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Daiso Issues Allergy Alert on Undeclared Soy in Matsunga Mini Shiruko Sand Biscuits

January 30, 2023 By The FDA

Sovos Brands Intermediate, Inc. Issues Allergy Alert on Undeclared Egg in Rao’s Slow Simmered Soup, Labeled as Chicken & Gnocchi but Containing Vegetable Minestrone

January 27, 2023 By The FDA

Edgewell Personal Care Issues Voluntary Nationwide Recall of Banana Boat Hair & Scalp Sunscreen Due to the Presence of Benzene – UPDATED

January 26, 2023 By The FDA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Properly Tied Recalls Children’s Lounge Pants Due to Violation of Federal Flammability Standards and Burn Hazard

January 25, 2023 By The CPSC

Snack Innovations Inc. Conducts Voluntary Recall on a Limited Quantity of Drizzilicious Mini Rice Cakes 4oz & .74oz and Popcorn 3.6oz Products in the U.S. Due to Undeclared Peanut Allergen on Packaging

January 25, 2023 By The FDA

Almondy is Initiating a Recall of a Limited Quantity of Almondy Chocolate Cake with Daim 14.1oz

January 25, 2023 By The FDA

SkinnyDipped® Issues Allergy Alert on Undeclared Peanuts in a Limited Number of SkinnyDipped® Dark Chocolate Nut Products

January 20, 2023 By The FDA

Lifetime Brands Recalls Hot Chocolate Pots Due to Fire Hazard; Sold Exclusively at Williams-Sonoma

January 18, 2023 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

SkinnyDipped® Issues Allergy Alert on Undeclared Peanuts in a Limited Number of SkinnyDipped® Dark Chocolate Nut Products

January 20, 2023 By The FDA

Lifetime Brands Recalls Hot Chocolate Pots Due to Fire Hazard; Sold Exclusively at Williams-Sonoma

January 18, 2023 By The CPSC

Sakar International Recalls Multi-Purpose Helmets Due to Risk of Head Injury

January 18, 2023 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Daiso Issues Allergy Alert on Undeclared Soy in Matsunga Mini Shiruko Sand Biscuits
  • Sovos Brands Intermediate, Inc. Issues Allergy Alert on Undeclared Egg in Rao’s Slow Simmered Soup, Labeled as Chicken & Gnocchi but Containing Vegetable Minestrone
  • Edgewell Personal Care Issues Voluntary Nationwide Recall of Banana Boat Hair & Scalp Sunscreen Due to the Presence of Benzene – UPDATED
  • Joy Joy’s Bakery Issues Allergy Alert on Undeclared Wheat in Ube Spanish Bread, Ube Ensaymada, and Ube Roll
  • ZLINE Expands Recall of Gas Ranges to Include 48-inch Gas Ranges Due to Serious Risk of Injury or Death from Carbon Monoxide Poisoning
  • Properly Tied Recalls Children’s Lounge Pants Due to Violation of Federal Flammability Standards and Burn Hazard
  • Snack Innovations Inc. Conducts Voluntary Recall on a Limited Quantity of Drizzilicious Mini Rice Cakes 4oz & .74oz and Popcorn 3.6oz Products in the U.S. Due to Undeclared Peanut Allergen on Packaging
  • Almondy is Initiating a Recall of a Limited Quantity of Almondy Chocolate Cake with Daim 14.1oz
  • SkinnyDipped® Issues Allergy Alert on Undeclared Peanuts in a Limited Number of SkinnyDipped® Dark Chocolate Nut Products
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in